Novel therapeutic approach identified for overcoming resista

Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove challenging to treat, with survival among relapsed or resistant cases falling between 30-50%.

Related Keywords

Texas , United States , Xin Huang , Zhejiang , China , Peking , Beijing , Xu Yang , Shaanxi , Charles Mullighan , Seth Karol , Steven Kornblau , Junj Yang , Xiaofan Zhu , Sheetal Bhatara , Yizhen Li , Yingchi Zhang , Satoshi Yoshimura , Nitin Jain , Jiyang Yu , Marina Konopleva , Jingliao Zhang , Hiroto Inaba , William Evans , Wenjian Yang , Elisabeth Paietta , Elias Jabbour , Mark Litzow , Huanbin Zhao , Leukemia Research , Albert Einstein College Of Medicine , Children Research Hospital , Baldrick Foundation , University Of Texas Md Anderson Cancer Center , National Institutes Of Health , Department Of Defense , Drug Administration , University Of Chicago , Research Hospital , Pharmaceutical Sciences , Computational Biology , Ching Hon Pui , Fahad Nassar Al Rashid Endowed Chair , Nature Cancer , Chinese Academy , Medical Sciences , Peking Union Medical , Peking Union Medical College , Mayo Clinic , Wendy Stock , Cancer Center , Albert Einstein College , Lei Yan , Liang Ding , National Institutes , Cell , Dwell Development , Leukemia , Acute Lymphoblastic Leukemia , Asparaginase , B Cell , Dancer , Chemotherapy , Children , Drugs , Gene , Hospital , Laboratory , Pharmacy , Protein , Research , Humor ,